Total assets increased 121.7%
Total assets changed +121.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Total assets changed +121.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Shares outstanding changed +57.2% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Working capital / assets changed +12747 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed +74.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating income changed -15.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Net income changed -57.7% from the comparable as-filed period.
Cash & equivalents changed +137.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating cash flow changed -22.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current assets changed +181.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current liabilities changed -53.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current ratio changed +510.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed +100.6% from the comparable as-filed period.
Trade receivables changed -32.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Cost of revenue changed +4.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital changed +156.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Stockholders' equity changed +413.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Gross profit changed -5.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.